Johnson has more than 25 years of experience in the pharmaceutical industry. She joins Catalent after having been vice president of quality assurance for GE Healthcare Biosciences, Medical Diagnostics, in Buckinghamshire, England. Before GE, Johnson was quality director for Baxter Healthcare’s Europe operations. Prior to that, she was with Rhone Poulenc Rorer as quality manager for Sterile Products and Microbiology, in Essex, England. Earlier in her career, she held quality and microbiology positions with Berk Pharmaceuticals in East Sussex, England, and Medicines Testing Laboratory, Edinburgh, Scotland.
Johnson holds a Post Graduate Diploma (PGDip) in Industrial Pharmaceutical Studies with Distinction from Brighton University and has a Bachelor of Science Honors Degree (BSc Hon) in Biological Sciences/Microbiology from North East Surrey College of Technology. She is eligible for nomination as a Qualified Person under the permanent provision of EEC Directive 75/319 and was appointed as a Qualified Person Assessor by the UK Institute of Biology in 1998, currently the vice chair of the IOB QP Assessor panel.
“I am pleased to welcome Sharon to the Catalent executive team,” said John Chiminski, president and chief executive officer of Catalent. “Her expertise and leadership skills will contribute significantly to extending and continuously improving Catalent’s long track record of product quality and regulatory compliance. I also want to recognize Ed Thiele’s many invaluable contributions during his time at Catalent and wish him well in his forthcoming retirement.”
Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology, and consumer healthcare companies in nearly 100 countries. For more information, visit www.catalent.com.